Elon Musk's neurotechnology company Neuralink received approval from the Food and Drug Administration (FDA) to perform in-human clinical trials.

The announcement was made via the Neuralink Twitter account, stating "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."

Neuralink is developing an implantable brain-computer interface and has been testing its devices using live animals. Now it seems the company can move on to testing on human subjects, but Neuralink's tweet makes it clear they aren't ready to recruit people for the clinical trial just yet. If you want "in," then stay tuned for Neuralink to "announce more information on this soon!"

The company may be setting impossibly high expectations, but if successful, Neuralink hopes to create a brain interface that can "restore autonomy to those with unmet medical needs today and unlock human potential tomorrow." However, the company was placed under investigation earlier this year for alleged mishandling of monkey brain implants. Clinical trials involving humans will only increase the scrutiny of its practices.